All news articles for September 2012

Fercy receives FDA warning letter

Fercy receives FDA warning letter

Fercy Personal Care Products received an FDA warning letter after quality staff handed inspectors just two pages from a notebook as ingredient records.

Big Pharmas to battle R&D bottlenecks

Big Pharmas team to tackle trial bottlenecks

The ten biggest drugmakers in the world want faster, more efficient R&D and claim a new non-profit organisation they formed last week is the solution to the industries development bottlenecks.

Pfizer signs Chinese CMO JV in China

Pfizer inks generics CMO JV with Hisun

By Gareth Macdonald

Pfizer and manufacturing partner Zhejiang Hisun Pharmaceuticals will set up a dedicated research centre to develop drugs for the Chinese market.

Recipharm given the go-ahead in France

Recipharm gets OK in France

Swedish CDMO Recipharm has been cleared by French regulators to fill biotech drug products at its site in Tours.

Celerion gets AAHRPP certification

update

Celerion OKed by patient rights group

US CRO Celerion has been awarded full accreditation by the Association for the Accreditation Human Research Protection Programs (AAHRPP), a group that assess patient safety and ethical concerns.